1. Market Research
  2. > Pharmaceutical
  3. > Drug Development Market Trends
Drug Discovery Technologies

Drug Discovery Technologies

  • March 2021
  • 193 pages
  • ID: 6039548
  • Format: PDF
  • BCC Research


Table of Contents

Report Scope:
In recent years, the drug discovery technologies industry has seen remarkable developments and rapid progress.This report focuses on the global drug discovery technologies market and provides an updated review to include basic design and its applications in different disease areas.

The drug discovery technologies include high-throughput screening, bioanalytical instruments, cell-based assays and reagents, genomics, bioinformatics, proteomics, and few others, like combinatorial chemistry, metabolomics, nanotechnology and system biology.These technologies are further classified into subcategories for the purpose of this report.

The five main disease application areas described in this report concern different cancer diseases, immunological diseases, neurological diseases, cardiovascular diseases and others, including metabolic, endocrinology and genetic diseases.

The report also covers the market by end-user for drug discovery technologies, segmented into biopharmaceutical companies, research and academia, and contract research organizations (CROs).

This report is global in scope and includes an analysis of the various regulatory environments, advancements, new products, market projections and market shares.Also, the report includes relevant patent analysis and comprehensive profiles of companies that lead the drug discovery technologies market.

The geographical regions covered are North America, Europe, Asia-Pacific and the Rest of the World. Detailed analyses of major countries such as the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India are covered in regional segments. For market estimates, data is provided for 2019 as the base year, 2020, and forecast through year-end 2025. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:
- 31 data tables and 16 additional tables
- An overview of the global market for drug discovery technologies
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, and projections of compound annual growth rates (CAGRs) though 2025
- Evaluation of market forecast, pipeline analysis of new products, regulatory scenarios and detailed analysis of drivers, challenges, and opportunities affecting market growth
- Market share analysis of drug discovery technologies based on type, application, end-user, and region
- Information on reverse transcription-polymerase chain reaction (qRT-PCR), and next-generation sequencing (NGS) and coverage of bioanalytical instruments used for drug discovery
- Information on pharmacokinetics and pharmacodynamics, and classification of techniques used in drug discovery
- Discussion on bioinformatics as platform for drug discovery and comparison between proteomics and genomics drug discovery technology
- Detailed description of COVID-19 including symptoms and progression, its effect on medical tourism and insurance providers and coverage of government expenditure on COVID-19
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Comprehensive company profiles of major players of the industry, including Thermo Fisher Scientific, General Electric Co., Agilent, Illumina, Merck KGaA and Bio-Rad Laboratories

The global market for drug discovery technologies was valued at $REDACTED billion in 2019.The market is expected to grow at a compound annual growth rate (CAGR) of REDACTED% to reach $REDACTED billion by 2025.

The drug discovery industry witnessed growth in the past several years owing to progress in biochemical, translational and molecular studies in biomedical research.These technologies are commercially employed in the development of new and efficient drug candidates.

The booming healthcare sector and increased government funding have aided notable growth in this market. The delineation of mechanistic details and the underlying mechanisms of drug-target interaction have paved the way for more accurate and effective therapies.

The growing field of drug discovery and development is enabling researchers to focus on discovering essential lead compounds for different forms of cancer and other diseases.Biopharmaceutical companies and various research institutes are conducting research in the field of drug discovery technologies.

Globally, research institutes and biopharmaceutical companies are exploring several molecular and biochemical aspects to develop mechanistic approaches for drug discovery. Various technologies, such as high-throughput screening, proteomics and genomics, including quantitative reverse transcription-polymerase chain reaction (qRT-PCR), next-generation sequencing (NGS) and many others, are being widely used for cellular analysis.

A rise in R&D, increasing incidences of various life-threatening diseases, and the increasing global population are all market drivers. The companies in this industry are focusing on enhancing biomedical research and the advancement of superior technologies in order to provide better quality treatments and therapies.

Collaborative efforts of researchers and the pharmaceutical industry are establishing various promising future drug candidates.Drug discoveries find applications in cardiovascular, neurological, cancer and other disease areas.

However, the rapid spread of COVID-19 has thrown countless businesses into a frenzy. The healthcare industry, in particular, is facing growing pressure to rapidly produce tests needed in nearly every region around the world.

The virus has created unprecedented challenges for the healthcare industry.COVID-19 has put the healthcare industry at center stage with the remarkable demand for diagnostic tests, personal protective equipment (PPE), ventilators and other critical medical supplies.

Moreover, for the unusual measures underway to rapidly ramp up manufacturing capacity and capabilities, healthcare leaders are also looking outside their normal sector boundaries to explore creative solutions to supplement further capacity, like partnerships with companies outside the sector, open-source equipment design and deployment of medically trained employees to support public-health needs.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on